Measuring anticholinergic exposure in patients with dementia: A comparative study of nine anticholinergic risk scales DOI
Oriol Turró‐Garriga, Laia Calvó‐Perxas, Joan Vilalta‐Franch

и другие.

International Journal of Geriatric Psychiatry, Год журнала: 2018, Номер 33(5), С. 710 - 717

Опубликована: Янв. 2, 2018

Objective To describe the prevalence and concordance of anticholinergic exposure according to 9 published scales, quantify relative weight drug subtypes included in each scale, identify clinical variables related exposure. Methods Observational cross‐sectional study using 5323 cases dementia diagnosed 7 hospitals public health care system Health Region Girona (Spain) between 2007 2014 registered by Registry Dementias (ReDeGi). We used Pharmacy database that includes all drugs prescribed specialist primary physicians dispensed pharmacies. calculated scoring rules scale. Age, gender, place residence, subtype, Clinical Dementia Rating score, Mini‐Mental Status Examination Blessed Score at moment diagnose were retrieved from ReDeGi. Results Prevalence annual ranged 36.3% 69.0% different among scales was poor moderate, central nervous accounted most for Being a nursing home, having depressive symptoms, non‐Alzheimer's number treatments, severity main determinants Conclusions There is large difference outcomes risk scales. Clinicians researchers should be aware these differences when instruments patients with dementia.

Язык: Английский

Anticholinergic burden of long-term medication is an independent risk factor for the development of postoperative delirium: A clinical trial DOI
Anika Mueller, Claudia Spies,

Rahel Eckardt

и другие.

Journal of Clinical Anesthesia, Год журнала: 2019, Номер 61, С. 109632 - 109632

Опубликована: Окт. 24, 2019

Язык: Английский

Процитировано

37

Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia DOI
Martin Taylor‐Rowan,

Olga Kraia,

Christina Kolliopoulou

и другие.

Cochrane library, Год журнала: 2022, Номер 2022(8)

Опубликована: Авг. 22, 2022

Язык: Английский

Процитировано

22

Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment DOI Creative Commons

Sabrina Pistorio,

Gianluca Scotto Di Tella,

Vittoria Canzanella

и другие.

Frontiers in Medicine, Год журнала: 2025, Номер 12

Опубликована: Фев. 12, 2025

Background Drugs with anticholinergic properties are frequently prescribed to patients cognitive impairment. The cholinergic system plays an important role in learning processes, memory, and emotions regulation. aim of this research is report use drugs a clinical population investigate the correlation between risk presenting more severe behavioral psychological symptoms (BPSD). Method Patients diagnosis subjective impairment, mild impairment (MCI) or dementia were recruited. Screening tests for (MMSE) functional status (ADL, IADL) performed. BPSD evaluated Neuropsychiatric Inventory (NPI). burden was calculated using ACB calculator. We compared at low adverse effects (ACB < 3) versus high ≥ 3). Chi-square test Mann–Whitney used compare two groups. A multiple linear regression performed identify factors associated higher NPI score logistic model built drug classes 3. Result total 173 (mean age 74 ± 7, men) included study; 132 3 (low risk) 41 ≥3 (high compared. No statistically significant differences found groups terms demographics (age, sex) anamnestic variables (education, marital status, family history dementia, hypertension, diabetes, smoking, dyslipidemia, atrial fibrillation, coronary heart disease alcohol). Significantly scores 47.3 34.8 25.5 24.6, p 0.001). showed lower MMSE (18.5 8.6 22.4 = 0.004) IADLs lost. In multivariate analysis, after adjusting age, sex, polypharmacy lost, only independent predictors score. Being on antipsychotics, antidepressants antidiabetic increased burden. Conclusion conclusion, might play as factor developing decline, independently from their degree

Язык: Английский

Процитировано

0

Comparison of Nine Instruments to Calculate Anticholinergic Load in a Large Cohort of Older Outpatients: Association with Cognitive and Functional Decline, Falls, and Use of Laxatives DOI

Tanja Mayer,

Andreas D. Meid,

Kai-Uwe Saum

и другие.

American Journal of Geriatric Psychiatry, Год журнала: 2017, Номер 25(5), С. 531 - 540

Опубликована: Янв. 23, 2017

Язык: Английский

Процитировано

35

The Relationship Between Anticholinergic Exposure and Falls, Fractures, and Mortality in Patients with Overactive Bladder DOI
Brandon T. Suehs, Eleanor O. Caplan,

Jennifer Hayden

и другие.

Drugs & Aging, Год журнала: 2019, Номер 36(10), С. 957 - 967

Опубликована: Июль 30, 2019

Язык: Английский

Процитировано

32

Meta-Analysis of the Effect of Cognitive Conflict on Physics Learning DOI Creative Commons
Fatni Mufit,

Asrizal Asrizal,

Reni Puspitasari

и другие.

Jurnal Penelitian & Pengembangan Pendidikan Fisika, Год журнала: 2020, Номер 6(2), С. 267 - 278

Опубликована: Дек. 31, 2020

Problems often experienced by students in learning physics are misconceptions and low understanding of concepts. One solution to this problem is apply conflict cognitive learning. The purpose study was analyze: (1) the problems that lead application learning, especially (2) stages used, (3) effect on education levels, (4) eye lessons, (5) competencies. This uses a meta-analysis method, namely analyzing similar scientific article documents. sample consisted 25 national international articles published 2012-2020. Data analysis used size equation, percentage techniques, descriptive analysis. results findings indicate: cause be applied poor concepts misconceptions, Learning has different stages, but most widely consists three main steps, Cognitive high being school, influence increasing overcoming physics. indicates good conceptual problems, school.

Язык: Английский

Процитировано

32

The Prognostic Utility of Anticholinergic Burden Scales: An Integrative Review and Gap Analysis DOI
Henry Ukachukwu Michael, Okechukwu Harrison Enechukwu, Marie‐Josée Brouillette

и другие.

Drugs & Aging, Год журнала: 2023, Номер 40(9), С. 763 - 783

Опубликована: Июль 18, 2023

Язык: Английский

Процитировано

10

Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research DOI
Mohammed S. Salahudeen, Prasad S. Nishtala

Drugs & Aging, Год журнала: 2016, Номер 33(5), С. 305 - 313

Опубликована: Апрель 1, 2016

Язык: Английский

Процитировано

28

Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort DOI Creative Commons

Abdelkrim Ziad,

Romain Olekhnovitch, Fabrice Ruiz

и другие.

Journal of Neurology Neurosurgery & Psychiatry, Год журнала: 2018, Номер 89(10), С. 1107 - 1115

Опубликована: Сен. 8, 2018

Previous studies have shown associations between the use of anticholinergics (AC) and cognitive performance in elderly, considering AC as a homogeneous set drugs. The present study aims to assess relationship exposure drugs middle-aged adults according potency drug class.Our cross-sectional used baseline data 34 267 participants aged 45-70 from Consultants des centres d'examen de santé la sécurité sociale (CONSTANCES) cohort. cumulative was measured using national reimbursement databases over 3-year period preceding assessment performance. Eight classes were differentiated. Episodic verbal memory, language abilities executive functions evaluated by validated neuropsychological tests. Analyses controlled on lifestyle health status variables.This showed negative association overall performances after adjustment. with possible effect Anticholinergic Cognitive Burden scale (ACB-1 score) only associated functions. across antipsychotics all assessed. Heterogeneous found for anxiolytics, opioids targeting gastrointestinal tract or metabolism. We did not find significant antihistamines, antidepressants, cardiovascular system other medications function.Association highly heterogeneous classes; this heterogeneity will be considered future studies.

Язык: Английский

Процитировано

28

Anticholinergic Burden and Dry Mouth in Middle-Aged People DOI
Antti Tiisanoja, Anna‐Maija Syrjälä, Arja M. Kullaa

и другие.

JDR Clinical & Translational Research, Год журнала: 2019, Номер 5(1), С. 62 - 70

Опубликована: Апрель 23, 2019

Introduction: Anticholinergic burden refers to the cumulative effect of taking 1 or more drugs with anticholinergic properties. At moment, little is known about association between and dry mouth. Objectives: The objective this article was study, whether an associated mouth among middle-aged people. Methods: study population included 1,345 people aged 46 y from Northern Finland Birth Cohort 1966 (NFBC1966) who took part in a clinical medical dental examination during 2012–2013. Medication data comprised both self-reported drug use information obtained national register. measured using 10 different scales. Dry defined on basis having either subjective feeling (xerostomia) objectively low unstimulated stimulated whole salivary flow rates (hyposalivation). Poisson regression models robust error variance were used estimate relative risk (RR). Regression adjusted for sex, smoking, diabetes, rheumatoid diseases, depressive symptoms, anxiety, total number drugs, antihypertensive drugs. Results: Approximately 14% participants reported xerostomia 2% had hyposalivation. RRs scales varied 1.05 1.68. scales’ 0.89 2.03 (<0.1 mL/min) 0.59 1.80 (<0.7 mL/min). Seven studied statistically significantly mouth, Conclusion: Most There considerable variation strength associations Knowledge Transfer Statement: findings suggest that dentists should take notice properties their harmful effects Dentists provide these patients necessary guidance how cope give them prophylactic measures against oral diseases

Язык: Английский

Процитировано

24